Status:
RECRUITING
Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization
Lead Sponsor:
University of Kansas Medical Center
Conditions:
Pelvic Congestive Syndrome
Pelvic Pain
Eligibility:
FEMALE
18+ years
Brief Summary
The primary objective is to quantify the degree of pain relief in patients undergoing gonadal vein embolization with coils as well as identify clinical or imaging factors that are predictive of a posi...
Detailed Description
Chronic pelvic pain affects almost 40% of women during their lifetime. Pelvic congestion syndrome (PCS) accounts for up to 30% of those with chronic pelvic pain. The most common underlying cause of PC...
Eligibility Criteria
Inclusion
- Female patients 18 years of age or older
- Meet the clinical and imaging criteria for the diagnosis of PCS and have no contraindications to coil embolization of the gonadal veins.
- Patients who are treated with coil embolization of the gonadal veins in the Interventional Radiology division between October 1, 2018 to October 1, 2019.
Exclusion
- Patients less than 18 years of age.
- Patients who are found to have an underlying cause of pelvic congestion syndrome unrelated to venous congestion and insufficiency. This includes, but is not limited to, nutcracker syndrome, or a mass resulting in extrinsic compression of the gonadal veins.
- Patients who have received prior surgical therapy for PCS, including bilateral salpingo-oophorectomy (TAH-BSO), gonadal vein resection, or gonadal vein ligation.
Key Trial Info
Start Date :
May 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 15 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03794466
Start Date
May 10 2019
End Date
December 15 2025
Last Update
April 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Kansas Medical Center
Kansas City, Kansas, United States, 66160